REVIEW ARTICLE
Rapid Serological Testing for Managing the COVID-19 Pandemic: A Review
Sultan M. Faheem1, *, Jancie D’Mello2, Sultan M. Kaleem3, Burra V. L. S. Prasad 2, Khalid Siddiqui4
Article Information
Identifiers and Pagination:
Year: 2021Volume: 11
First Page: 99
Last Page: 107
Publisher ID: TOBIOMJ-11-99
DOI: 10.2174/1875318302111010099
Article History:
Received Date: 31/3/2021Revision Received Date: 28/7/2021
Acceptance Date: 16/8/2021
Electronic publication date: 16/12/2021
Collection year: 2021
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
With the onset of the novel coronavirus disease pandemic (COVID-19) that emerged from Wuhan in China, the need of the hour can be summarized into two groups. The first one is a potent vaccine as a prophylactic measure to prevent the virus from infecting people, and the second is a rapid diagnosis of the disease to help healthcare professionals and government authorities to plan and control the spread and provide effective care and treatment. This review delves into the latter, describing the COVID-19 and its treatment, including the race for an effective vaccine, and highlighting the role of serological testing in managing the pandemic since a well-designed study to understand mechanisms and serological correlations of protective immunity is crucial for rational clinical and public health policies. In conclusion, swift vaccination and response tactics, such as social distancing, hand hygiene, wearing of masks, and, if required, lockdown practices continue to be important in managing the pandemic while carefully monitoring any possible outbreak due to the variants.
